Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Completed2
Recruiting1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT07740941Phase 2Recruiting
NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
Melanoma (Skin Cancer)Melanoma Stage IVMelanoma Stage M1+1 more
PrincipalinvestigatorStart date: 2026-08-06
NCT03620019Phase 2Completed
Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma
Cutaneous MelanomaMelanomaMelanoma (Skin)+2 more
PrincipalinvestigatorStart date: 2018-09-10

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT07740941Phase 2PrincipalInvestigator

NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma

Melanoma (Skin Cancer)Melanoma Stage IVMelanoma Stage M1+1 more
Recruiting
NCT03765229Phase 2PrincipalInvestigator

An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma

Melanoma
Completed
NCT03620019Phase 2PrincipalInvestigator

Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma

Cutaneous MelanomaMelanomaMelanoma (Skin)+2 more
Completed

All 3 trials loaded